What is being analysed here?

The TORCH panel evaluates the presence of antibodies produced by the immune system against the following infections:

• Toxoplasmosis: A parasitic infection that can be transmitted from mother to fetus during pregnancy. It can cause ocular infections, affect the central nervous system, and lead to brain and muscle cysts.
• Rubella: The rubella virus can cause conditions such as heart defects, growth delay, hearing loss, and blood disorders in the fetus if acquired early during pregnancy.
• Cytomegalovirus (CMV): A virus that can cause disease and severely affect newborns, including hearing loss, visual impairments, intellectual disability, and pneumonia. Herpes simplex: The herpes simplex virus can cause infections in the foetus during childbirth or through breast milk.

Additionally, the TORCH panel may include tests to detect other infections in newborns.

How is it used?

The TORCH panel analysis is used to:

• Detect infectious diseases in pregnant women.
• Evaluate congenital defects in newborns.
• Perform screening during pregnancy to prevent complications.

Why is this analysis performed?

The analysis is conducted to identify infections that could affect the foetus and to take preventive or treatment measures as needed.

When should the analysis be carried out?

It is recommended to perform the analysis when a pregnant woman is exposed to or suffers from a specific infectious disease, or if the newborn presents congenital defects that could be attributed to any of the diseases included in the panel.

Is there any sample required?

The determination is made from a sample of venous blood or through heel prick in newborns.

Is there any special preparation needed?

No special preparation is required for this test.

What are the normal values?

Normal values vary depending on the laboratory and the technique used. It is essential to consult with a physician to interpret specific results.

What do abnormal values indicate?

Abnormal values may indicate the presence of active infections or previous exposure to the diseases included in the TORCH panel. Interpretation should be done in consultation with a healthcare professional.